A MALDI-TOF MS library for rapid identification of human commensal gut bacteria from the class Clostridia
- 1Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland
- 2Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
- 3University of Basel, Basel, Switzerland
- 4Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
- 5Clinical Bacteriology and Mycology, University Hospital of Basel, Basel, Switzerland
- 6Interfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen, Germany
- 7Cluster of Excellence ‘Controlling Microbes to Fight Infections', University of Tübingen, Tübingen, Germany
- 8Functional Microbiome Research Group, Institute of Medical Microbiology, RWTH University Hospital, Aachen, Germany
- 9Institute of Microbiology of the University of Lausanne, University Hospital Centre (CHUV), Lausanne, Switzerland
- 10Duchossois Family Institute, Division of Infectious Diseases and Global Health, University of Chicago, Chicago, IL, United States
- 11BioAster, Paris, France
- 12PharmaBiome AG, Schlieren, Switzerland
A corrigendum on
A MALDI-TOF MS library for rapid identification of human commensal gut bacteria from the class Clostridia
by Asare, P. T., Lee, C.-H., Hürlimann, V., Teo, Y., Cuénod, A., Akduman, N., Gekeler, C., Afrizal, A., Corthesy, M., Kohout, C., Thomas, V., de Wouters, T., Greub, G., Clavel, T., Pamer, E. G., Egli, A., Maier, L., and Vonaesch, P. (2023). Front. Microbiol. 14:1104707. doi: 10.3389/fmicb.2023.1104707
In the original article, there was an error in the Data availability statement. The dataset deposited on the Zenodo link was incomplete and the MALDI spectra were named with the old taxonomy. We have now corrected these errors, added a few strains and taken out two strains with ambiguous spectra. We have uploaded the ClostriTof version 2.0 database plugin on Zenodo. The correct Data availability statement appears below.
“The datasets presented in this study can be found on Zenodo under the following link: https://zenodo.org/record/7773644#.ZCny2y8Rrfc.”
In the published article, there was an imprecision in the Conflict of interest. This sentence previously stated: “The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.” The correct Conflict of interest appears below.
“TW and VH were employed by PharmaBiome AG.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: human gut microbiota, Clostridia, MALDI-TOF MS, commensal bacteria, anaerobic, bacterial identification, culturomics, next-generation probiotics
Citation: Asare PT, Lee C-H, Hürlimann V, Teo Y, Cuénod A, Akduman N, Gekeler C, Afrizal A, Corthesy M, Kohout C, Thomas V, de Wouters T, Greub G, Clavel T, Pamer EG, Egli A, Maier L and Vonaesch P (2023) Corrigendum: A MALDI-TOF MS library for rapid identification of human commensal gut bacteria from the class Clostridia. Front. Microbiol. 14:1208177. doi: 10.3389/fmicb.2023.1208177
Received: 18 April 2023; Accepted: 19 April 2023;
Published: 22 May 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Asare, Lee, Hürlimann, Teo, Cuénod, Akduman, Gekeler, Afrizal, Corthesy, Kohout, Thomas, de Wouters, Greub, Clavel, Pamer, Egli, Maier and Vonaesch. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pascale Vonaesch, pascale.vonaesch@unil.ch
†Present addresses: Paul Tetteh Asare, Gnubiotics Sciences AG, SuperLab Suisse, Lausanne, Switzerland
Chi-Hsien Lee, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium
Vera Hürlimann, PharmaBiome AG, Schlieren, Switzerland
Adrian Egli and Aline Cuénod, Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland
‡These authors have contributed equally to this work